MODERATOR
:
SPEAKER
(S):
Dr. Jeffrey Carson, MD, Provost,and Professor of Medicine, Rutgers Robert Wood Johnson Medical School
First Results of the FOCUS Trial,,
Sherrill Slichter, MD, Director, Platelet Transfusion Research, Puget Sound Blood Center
Update on the PLADO Trial
Description
In this session, two eminent clinical investigators will be presenting the results of two recent and important randomized clinical trials in transfusion medicine. The Transfusion Trigger Trial for Functional Outcomes in Cardiovascular Patients Undergoing Surgical Hip Fracture Repair (FOCUS) trial investigated outcomes of patients with cardiovascular disease undergoing orthopedic surgery who received red cell transfusions at two different triggers. One speaker will present the first results from this trial. The Effects of Prophylactic Platelet Dose on Transfusion Outcomes (PLADO) trial investigated the effect of three different platelet doses on bleeding in patients undergoing chemotherapy or HPC transplantation. Another speaker will present new data from the PLADO trial.
**Audio file not received.
-
Assess the effect of platelet dose in prophylactic platelet transfusion.
-
Compare outcomes of surgical patients transfused at different hemoglobin triggers.
-
Describe the essential elements of randomized clinical trails in transfusion.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.